| INTRODUC TI ON
Although skeletal muscle tissue has the capacity to regenerate to some extent after an injury, significant tissue damage can leave the muscle permanently impaired, resulting in scar tissue formation. 1 A current strategy applied to repair damaged muscles involves the use of autologous muscle flaps. These flaps are harvested from a patient's healthy muscles and transplanted to the site of injury. 2, 3 Although this method is efficient, it has several drawbacks, such as donor site morbidity and limited muscle availability. [4] [5] [6] [7] [8] In recent years, tissue-engineering techniques have been harnessed to generate tissue constructs with the potential to replace and regenerate damaged tissues and organs. 9 A common method for fabricating engineered tissue is to seed cells onto a 3-dimensional (3D) matrix, where they then organize, either spontaneously or upon induction, into a tissue. 10 This approach can also be applied to help promote recovery of injured skeletal muscles by delivering constructs seeded with muscle cells onto the site of injury or by enhancing regeneration of native muscle tissue into transplanted engineered constructs. 11, 12 We have previously reported the fabrication and transplantation of engineered muscle grafts, constructed from a tri-culture of myoblasts, endothelial cells, and fibroblasts seeded onto 3D biodegradable scaffolds. [13] [14] [15] The grafts were cultured in vitro for up to
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Autologous muscle flaps are commonly used to reconstruct defects that involve muscle impairment. To maintain viability and functionality of these flaps, they must be properly vascularized and innervated. Tissue-engineered muscles could potentially replace autologous muscle tissue, but still require establishment of sufficient innervation to ensure functionality. In this study, we explored the possibility of innervating engineered muscle grafts transplanted to an abdominal wall defect in mice, by transferring the native femoral nerve to the graft. Six weeks posttransplantation, nerve conduction studies and electromyography demonstrated increased innervation in engineered grafts neurotized with the femoral nerve, as compared to non-neurotized grafts. Histologic assessments revealed axonal penetration and formation of neuromuscular junctions within the grafts. The innervation process described here may advance the fabrication of a fully functional engineered muscle graft that will be of utility in clinical settings.
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3 weeks to allow for myotube assembly from myoblasts. Endothelial cells and fibroblasts were added to support vascular integration into the host and to enhance the host angiogenic response after transplantation to a murine muscle defect. 14 Two weeks after transplantation, positive staining for skeletal muscle markers was observed in well-integrated and highly vascularized grafts. Such well-integrated engineered muscle grafts has the potential to eventually replace autologous muscle flaps, thereby precluding the need for muscle harvesting from the patient.
To effectively replace autologous muscle flaps, a means of innervating engineered muscle constructs must be developed because innervation is essential to muscle function and to prevent atrophy.
16,17
Innervation in autologous flaps is achieved by harvesting the tissue with its innervating nerve, which is later sutured into a local nerve at the damaged site. 4 Using this approach, axons of the local nerve can penetrate into the nerve component of the flap and innervate the muscle fibers within. However, in vitro fabricated tissue-engineered constructs that include such a nerve component are yet to be reported. The current study aimed to assess the potential of host innervation of transplanted engineered grafts. Engineered muscle constructs were transplanted to an abdominal wall muscle defect, after which the high-caliber femoral nerve was transected and retargeted to the engineered graft. Six weeks after transplantation, innervation was assessed by electrophysiology tests and immunofluorescence staining. All incubations were performed in a 5% CO 2 humidified incubator, set at 37°C.
| ME THODS

| Cell cultures
| Graft fabrication
Porous scaffolds were composed of 50% poly-l-lactic acid (PLLA;
Polysciences Inc.) and 50% poly (lactic-co-glycolic acid) (PLGA;
Boehringer-Ingelheim), both of which are approved by the Food and Drug administration (FDA) for several uses. [18] [19] [20] The scaffolds were fabricated using a previously described salt-leaching method. 21 In brief, PLLA and PLGA were dissolved (1:1) in chloroform to yield a solution of 5% (wt/vol) polymer, 0.24 mL of which was poured into molds containing 0.4 g sodium chloride particles. The particles had diameters of 212-600 μm to achieve pore sizes of the same range.
The solvent was allowed to evaporate, and the scaffolds were than immersed for 8 hours in distilled water (changed every hour) to leach the salt and create a structure with a network of interconnecting pores. The fabricated scaffolds measured ~1 mm in thickness and were cut to 6-mm-diameter circles in order to fit into the abdominal wall defect.
HUVEC-GFPs (0.5 × 10 ) were suspended in a mixture of 3 μL thrombin (20 U/mL, Sigma) and 3 μL fibrinogen (15 mg/mL, Sigma) to enhance cell attachment to the scaffold. The same tri-culture was used previously to efficiently fabricate vascularized engineered muscle grafts. 15 The cell suspension was uniformly seeded by slowly pipetting the suspension over the surface of the scaffold and into the network of interconnected pores. The cell-seeded construct was allowed to solidify (30 minutes, 37°C, 5% CO 2 ) in a 12-well plate.
After solidification, HUVEC-GFP medium (1 mL) and C2C12 medium (1 mL) were added to each well. Medium was replaced every other day. Grafts were cultured for 7-14 days to enable myotube assembly prior to transplantation. This time period was previously shown to be efficient for generating myotubes, with no differences in fiber diameter between scaffolds cultured for 7 or 14 days. 14 For the viability assay HUVEC that do not express GFP were used.
| Surgical procedure
The Committee of Ethics of Animal Experiments of the Technion granted approval for animal use in this study. Male athymic nude mice (7-9-week-old, Harlan Laboratories Inc.) with an inhibited immune system were used. To neurotize grafts (n = 8), a delicate circumferential dissection was performed to isolate the femoral bundle. The bundle was ligated at the proximal end with a 4-0 silk knot at knee level, cut, and reflected upward. Cautery was applied to the distal end of the bundle to avoid retrograde flow from the vessels. The proximal end of the femoral bundle was secured to the engineered graft with one 10-0 nylon suture. The blood vessels of the bundle were transposed along with the nerve to provide blood supply to the graft by sprouting new vessels as described previously. 15 In the non-neurotized control group (n = 7), the surgical procedure was executed in the same manner with one exception: the artery and vein of the bundle were separated from the femoral nerve and sutured to the engineered graft with no nerve component.
| Electrophysiologic assessment
Six weeks after transplantation, animals were anesthetized before the electrophysiological assessment.
Using an electromyograph (Medelec Synergy) with a concentric (coaxial) needle electrode, the electrical activity in the muscle grafts was recorded in the resting state. The activity was then classified as either normal or spontaneous. 22 Spontaneous activity was considered an indication of poor muscle innervation.
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Nerve conduction studies were performed to detect neurotized graft response to nerve stimulation. The compound muscle action potential (CMAP) was measured after an electrical current of 4.5 mA was applied for 0.1 msec to the femoral bundle, using monopolar disposable 28 G needle electrodes. To apply the current, the needle electrode was placed over the transferred part of the femoral bundle, which in the control group did not include the nerve, followed by measurement of the amplitude of a CMAP 24 within the engineered muscle graft. Control grafts were also evaluated to ensure that amplitudes measured in the neurotized grafts result from nerveconducted signal and not from electrical currents passing through random tissue. Close attention was paid to inserting the measuring needle electrode at mid-graft to avoid recording from the surrounding native muscle. In both groups, the stimulation was applied at equal distances from the graft. Native muscle CMAP was recorded in the quadriceps femoris muscle.
| Imaging
Following electrophysiological assessment, engineered muscle grafts were removed and placed in paraformaldehyde 4% solution for 
| Statistical analysis
| RE SULTS
Highly porous polymeric scaffolds composed of biocompatible, biodegradable PLLA and PLGA ( Figure 1A and B) were seeded with myoblasts, endothelial cells, and fibroblasts ( Figure 1C ). One day post-seeding, GFP-expressing endothelial cells were observed on the scaffold, confirming cell attachment to the polymer ( Figure 1D ).
One week thereafter, cells were seen viable and uniformly distributed on the scaffold ( Figure 1E ) and formed desmin-positive myotubes ( Figure 1F ).
One week to 2 weeks post-seeding, engineered, muscle grafts were transplanted to a mouse abdominal wall defect (Figure 2A ).
The femoral bundle was sutured to the grafts, with or without the femoral nerve, to establish neurotized grafts and control grafts, respectively, which were able to provide adequate coverage of the abdominal wall defect ( Figure 2B and C). Six weeks following transplantation the femoral bundle and the site of the abdominal wall defect were re-exposed for electrophysiologic assessment. Neurotized and control grafts appeared viable and well integrated with the native abdominal muscle.
Muscle activity was recorded in the grafts in the resting state. Both spontaneous EMG activity ( Figure 3A ) and silent EMG activity ( Figure 3B ) were detected in the grafts. In neurotized grafts, no spontaneous activity was recorded at rest ( Figure 3C ). In contrast, spontaneous, unsynchronized activity was recorded in 5 of 7 control, non-neurotized grafts ( Figure 3C ).
In the remaining 2 grafts, no spontaneous activity was measured, suggesting that local nerve branches from the abdomen had penetrated the graft.
To further assess functional innervation of the engineered grafts, the transferred part of the femoral bundle, was electrically stimulated. CMAP amplitudes in the neurotized grafts (n = 8) and non-neurotized grafts were then measured (n = 7). To ensure that the measured amplitudes resulted from nerve conducted signal as explained in the Methods, control non-neurotized grafts were also assessed despite not being attached to the femoral nerve.
Amplitudes were also measured in a native muscle to establish a reference CMAP from a healthy innervated muscle ( Figure 4A ).
CMAP was successfully recorded in all neurotized grafts ( Figure 4B ), whereas all control non-neurotized grafts failed to generate a CMAP proper integration into the host muscle, with no to minimal fibrosis 13 ( Figures 5A, B and S1 ). The graft was vascularized in accordance with previous reports, 13, 15 and myotubes were present within the graft ( Figure 5C , D, and E).
In the neurotized grafts, the femoral nerve was still intact 6 weeks after surgery and was observed penetrating the grafts, as determined by beta 3 tubulin staining ( Figure 6A ). Nerve sprouting was observed at mid-graft ( Figure 6B and C). In both groups, axons were seen penetrating the graft from the surrounding abdominal muscle, likely axons of thoracoabdominal intercostal nerves 25 ( Figure 6D and E). However, a larger number of axons was detected inside the neurotized grafts compared to the control, non-neurotized grafts ( Figure 6F ).
The in vitro culture period of 1 or 2 weeks did not show a significantly different effect over presentation of spontaneous activity NMJs were detected inside all grafts of the 2 groups and were smaller and less developed than native NMJs ( Figure 7A and B).
The NMJs appeared in clusters and were spread evenly throughout the graft. Co-localization of axons and acetylcholine receptors ( Figure 7C ) and co-localization of synaptophysin and acetylcholine receptors ( Figure 7D ) inside the grafts were observed, suggesting the formation of functional synapses.
| D ISCUSS I ON
Innervation of tissue-engineered muscle constructs is a requirement for their future clinical application. 26 However, very little research has been reported on innervating tissue-engineered skeletal muscle constructs. 26 Previous studies involving in vitro co-cultures of myoblasts and neurons have described the development of NMJs between axons and muscle cells, along with nerve-induced contractions of skeletal myotubes in vitro. [27] [28] [29] [30] [31] Moreover, cultured rat EMG recordings provided further evidence of graft innervation, with none of the neurotized versus 71.5% of the non-neurotized control grafts exhibiting spontaneous activity, which is associated with poor innervation. 22 The possibility that femoral nerve axons have failed to innervate and stimulate the graft and that therefore the measured CMAP reflects surrounding host muscle innervation by axons of the femoral nerve can be excluded by examining the EMG recordings. If this were the case, we would expect to see no differences in spontaneous activity between the neurotized grafts and the control grafts. If the femoral nerve had failed to innervate and stimulate the graft, the presence of non-innervated muscle would have still contributed to the recording of spontaneous activity such as in the control. Furthermore, innervation of the surrounding host muscle by the femoral nerve should be unlikely due to activitydependent mechanisms that prevents innervated muscle fibers from being reinnervated by additional axons. 38 We assume that the lack of spontaneous activity in some of the control grafts resulted from the penetration of small branches of abdominal wall nerves observed by immunofluorescence.
Because the majority of control grafts exhibited spontaneous activity during EMG recording, we conclude that the penetration of Badylak's group used porcine decellularized extracellular matrix in 5 human patients who sustained severe skeletal muscle injuries, to induce regeneration of muscle tissue into the transplanted matrix. 47 The results were encouraging; however, 2 patients failed to show functional improvements, despite histologic indications of muscle regeneration. It is possible that a surgical nerve transfer at the time of or shortly after transplantation in future similar trials would result in better functional outcome.
The innervation process described here may promote the creation of functional engineered muscle grafts of clinical relevance.
Such innervated functional muscles, engineered on demand, personally tailored to the defect size and shape, will have a major impact on reconstructive surgery and regenerative medicine, 26 including repair of large abdominal wall full-thickness defects, facial paralysis, and other defects necessitating a working muscle for reconstruction.
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